European OTC Market In Brief
This article was originally published in The Tan Sheet
Executive Summary
Boomtown Kazakhstan: Ukraine and Kazakhstan have emerged as top OTC market opportunities in Central and Eastern Europe, according to consultant Duncan McLaughlin of CEE Business Development. "Don't forget Kazakhstan. It's a booming economy - get your suitcase, get your briefcase and go out there and do the deals," McLaughlin said April 11 at Nicholas Hall's Insight 19th Annual European OTC Conference in Athens. Non-pharmacy access to OTC drugs is not consistent across countries in the region, but most are liberalizing their regulations, he added. In five to 10 years, "I think we will see a lot more non-pharmacy sales in CEE than what we are seeing in mainstream Western Europe," he said. Like other markets, drug firms have better chances for success in CEE with "products and brands with really tangible and communicable differences. We all know that - we don't always do that," McLaughlin said...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning